期刊文献+

在职临床药师参与临床实践培养模式探讨 被引量:18

Discussion on Training On-the-job Pharmacist in Clinical Practice
暂未订购
导出
摘要 目的:探求我国快速培养在职临床药师的方式、方法及有效模式。方法:参照国内、外临床药师的培养过程和现状,比较国内、外临床药师培养的背景、制度和政策,并结合自身的工作经验,提出我国较为快速的在职临床药师的培养模式。结果与结论:我国的在职临床药师培养,只有分步骤进行,包括从理论学习和临床实践技能、考核指标的制订与评价,以及学术论文撰写等方面入手,才能尽快培养出真正意义上的临床药师参与临床实践,从而保证安全、合理、有效、经济用药,减少卫生资源的浪费。 OBJECTIVE:To explore an effective mode and way to quickly train on-the-job pharmacist to become clinical pharmacist in China. METHODS: With the reference to the process and current situation of clinical pharmacist training both domestically and abroad, the background, systems and policies about clinical pharmacist training were compared and the personal working experience of the author was considered, then an efficient mode for domestic on-the-job pharmacist training was put forward. RESULTS & CONCLUSION: On-the-job pharmacist training in China should be carried out in steps,which includes theoretical study and clinical practice, establishment of evaluation system, and writing of scientific papers, only by doing this can we really train the clinical pharmacists in clinical practice, ensure the safe, rational, effective and economic medication and reduce the waste of health resources.
出处 《中国药房》 CAS CSCD 北大核心 2005年第15期1124-1126,共3页 China Pharmacy
基金 中华医院管理学会研究课题
关键词 在职临床药师 培养 临床实践 评价指标 On-the-job clinical pharmacist Training Clinical practice Evaluation index
  • 相关文献

参考文献10

  • 1颜青,吴永佩.培养临床药师,发展临床药学[J].中国药房,2000,11(3):107-108. 被引量:72
  • 2叶德泳,王继鸣,程务本,张楠森.中国临床药师教育20年的回顾与展望[J].中国临床药学杂志,2001,10(1):64-66. 被引量:22
  • 3汤晓怀,王艳.我院开展临床药学服务的实践及意义[J].中国药房,2005,16(4):311-312. 被引量:24
  • 4Hammond RW, Schwartz AH, Campbell MJ, et al, Collaborative drug therapy management by pharmacists-2003[J ]. Pharmacotherapy, 2003,23(9) : 1 210.
  • 5American society of hospital pharmacises.ASHP statement on principles for including medications and pharmaceutical care in health care systems[J]. Am J Hosp Pharm , 1993,50: 756.
  • 6Manasse HR Jr.Medication use in an imperfect world,I: drug misadventuring as an issue of public policy[J] .Am J Hosp Pharm , 1989,46:1 093.
  • 7Ernst FR, Grizzle AJ.Drug related morbidity and mortality : updating the cost - of - illness model [ J ] . J Am Pharm Assoc , 2001,41 : 192.
  • 8Isetts BJ, Brown LM, Schondelmeyer SW, et al. Quality assessment of a collaborative approach for decreasing drug - related morbidity and achieving therapeutic goals[J ] .Arch Intern Med ,2003, 163(15) : 1 813.
  • 9Agency for healthcare research and quality. Patient safety task force fact sheet [EB/ OL] .http:// www.ahrq.gov/qual/taskforce/psfactst .htm.April 2001.
  • 10Kohn LT, Corrigan J M, Donaldson MS, et al . To err is human: building a safer health system [M] . Washington, DC: National Academy Press, 1999: 312.

二级参考文献7

共引文献112

同被引文献82

引证文献18

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部